Lumida
/ESCA
⌘K
Escalade Inc

Escalade Inc

ESCA
$19.24USD-0.67%-0.13 today

MARKET CAP

265.6M

P/E (TTM)

17.2x

FWD P/E

17.4x

DAY RANGE

$19 – $20

52W RANGE

$11
$21

AI Summary

Stalk
Sell NowMedium

ESCA is in a Stage 4 decline with confirmed lower highs and lower lows, trading below downward-sloping EMAs and the 50DMA. An active Bearish Pivot Point pattern signals structural downside repair. Medium-term bias is bearish, and short-term conditions favor immediate selling into overhead resistance for continuation participation.

  • Gold Tip Archery acquisition lifted Q1 net sales to $55.8M.
  • Gross margin expanded 400bps YOY to 30.7% via cost-cutting.
  • Net sales fell 2.2%, underscoring uneven consumer spending.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Escalade, Inc. (NASDAQ: ESCA) is a prominent player in the recreational and sporting goods industry, specializing in the manufacturing and distribution of products such as archery equipment, billiards supplies, and fitness accessories. The company is actively positioned to leverage niche markets, such as archery and indoor games, particularly amid economic shifts that see consumers favoring at-home recreational activities. With recent strategic acquisitions like Gold Tip Archery, Escalade aims to enhance its brand strength and operational efficiency while addressing evolving consumer preferences against a backdrop of potential economic headwinds.

Bull says

  • Gold Tip Archery acquisition lifted Q1 net sales to $55.8M.
  • Gross margin expanded 400bps YOY to 30.7% via cost-cutting.
  • Free cash flow rose to $6.1M from $3.8M, funding reinvestment.
  • Interest-rate sensitivity score implies stronger debt management amid rising rates.
  • Momentum factors remain positive, indicating potential upward stock trend.
  • Consumer shift to at-home recreation drives demand for core products.

Bear says

  • Net sales fell 2.2%, underscoring uneven consumer spending.
  • High leverage heightens financial risk amid increased capital expenditures.
  • Negative analyst revisions signal downward earnings expectations.
  • Planned capex increase risks cost overruns with softer demand.
  • Competitive pricing pressure may erode margins through promotions.
  • Low size and liquidity metrics reflect weak institutional support.